On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
40° Feels Like: 30°
Wind: NE 21 mph Past 24 hrs - Precip: 0.26”
Current Radar for Zip

Today

Rain/Wind 41°

Tonight

Rain 37°

Tomorrow

PM Showers 58°

Alerts

Blackstone, Lion Capital to bid for GSK's Lucozade, Ribena: report

Signage is pictured on the company headquarters of GlaxoSmithKline in west London July 21, 2008. REUTERS/Toby Melville
Signage is pictured on the company headquarters of GlaxoSmithKline in west London July 21, 2008. REUTERS/Toby Melville

(Reuters) - Private equity firms Blackstone and Lion Capital have teamed up to make a formal bid worth more than a billion pounds for Lucozade and Ribena, the two soft drink brands put up for sale by drugmaker GlaxoSmithKline , Sky News reported on Sunday.

GSK has been increasingly focusing its consumer health operations on emerging markets and put Lucozade and Ribena -- brands that are big sellers in Britain but lack global reach -- up for sale as they no longer fit in with the company's portfolio.

Last month, GSK said it had appointed JPMorgan and Greenhill to advise it on the sale.

Blackstone and Lion Capital have appointed bankers at Rothschild to advise them on their bid, Sky News reported.

Both Blackstone and Lion Capital could not be reached for comment outside regular business hours. (Reporting by Abhishek Takle in Bangalore; Editing by Marguerita Choy)

Comments